Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin.
The bronchopulmonary and plasma pharmacokinetics of clarithromycin (CLA; 500 mg given twice daily for nine doses) or azithromycin (AZ; 500 mg for the first dose and then 250 mg once daily for four doses) were assessed in 41 healthy nonsmokers. Bronchoalveolar lavage was performed at 4, 8, 12, or 24...
Bewaard in:
| Gepubliceerd in: | Antimicrob Agents Chemother |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society for Microbiology (ASM)
1996
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163537/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8891147/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.10.2375 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|